OGR1 (GPR68) and TDAG8 (GPR65) Have Antagonistic Effects in Models of Colonic Inflammation

Leonie Perren1, Moana Busch1, Cordelia Schuler1

  • 1Department of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland.

Insights

G-protein-coupled receptors ovarian cancer GPR1 (OGR1) and T cell death-associated gene 8 (TDAG8) play roles in inflammatory bowel disease. OGR1 deficiency alleviates intestinal damage, suggesting both are potential therapeutic targets.

Area of Science:

  • Gastroenterology and Immunology
  • Molecular and Cellular Biology

Background:

  • G-protein-coupled receptors (GPRs) like ovarian cancer GPR1 (OGR1/GPR68) and T cell death-associated gene 8 (TDAG8/GPR65) are pH sensors implicated in inflammatory bowel disease (IBD).
  • OGR1 and TDAG8 exhibit opposing roles in inflammation, necessitating an understanding of their predominant physiological relevance.

Purpose of the Study:

  • To investigate the individual and combined roles of OGR1 and TDAG8 in murine models of intestinal inflammation.
  • To determine the predominant receptor in mediating inflammatory responses and intestinal damage in IBD.

Main Methods:

  • Utilized spontaneous and acute murine colitis models with targeted gene deletion of OGR1 and TDAG8.
  • Assessed disease severity via clinical scoring and analyzed colonic tissue using quantitative polymerase chain reaction (qPCR) and flow cytometry (FACS).

Main Results:

  • In acute colitis, OGR1 deficiency significantly reduced clinical scores, whereas TDAG8 deficiency or combined deficiency showed no significant difference from wildtype (WT).
  • In spontaneous colitis, OGR1 deficiency decreased inflammation, while TDAG8 deficiency exacerbated it. Triple knockout mice showed reduced inflammation compared to TDAG8-deficient mice.
  • Absence of OGR1 diminished pro-inflammatory cytokines in TDAG8-deficient mice and alleviated intestinal damage associated with TDAG8 deficiency, which was linked to increased IFNγ+ T-lymphocytes and IL-23 T-helper cells.

Conclusions:

  • OGR1 plays a significant protective role in intestinal inflammation, counteracting the detrimental effects of TDAG8 deficiency.
  • Both OGR1 and TDAG8 are identified as potential therapeutic targets for managing inflammatory bowel disease.